TransMedics Reports Third Quarter 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/4/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
TransMedics (TMDX) surges 40% after raising sales forecast
November 7, 2023 6:53 AM ESTTransMedics Group (NASDAQ: TMDX) saw its stock rise more than 40% in pre-market Tuesday trading after the organ transplant company raised its full-year sales forecast.
In addition to the improved outlook, the health-care firm reported third-quarter revenue that exceeded the average analyst... More
TransMedics Group (TMDX) surges 30% on strong revenue beat and guidance
November 6, 2023 4:21 PM ESTTransMedics Group (NASDAQ: TMDX) surges after strong Q3 revenue beat and raised FY revenue guidance:
reported Q3 EPS of ($0.78), $0.62 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $66.4 million versus the consensus estimate of $49.19 million.sees FY 2023... MoreTransMedics Group (TMDX) Q3 Revenue Beat; Raises FY Revenue Guidance
November 6, 2023 4:20 PM ESTTransMedics Group (NASDAQ: TMDX) reported Q3 EPS of ($0.78), $0.62 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $66.4 million versus the consensus estimate of $49.19 million.
GUIDANCE:
TransMedics Group sees FY2023 revenue of $222-230 million, versus prior of... More
